Geppetti P, Del Bianco E, Santicioli P, Lippe I T, Maggi C A, Sicuteri F
Institute of Internal Medicine, University of Florence, Italy.
Brain Res. 1990 Feb 26;510(1):58-62. doi: 10.1016/0006-8993(90)90727-s.
Substance P- and calcitonin gene-related peptide-like immunoreactivities (SP-LI and CGRP-LI, respectively) were measured in superfusates of either superior sagittal sinus and transverse sinuses and attached dura mater or dura mater alone of guinea pig. Exposure of cerebral venous sinuses to capsaicin (1 microM) evoked the release of both SP-LI and CGRP-LI, which was no longer observed upon second challenge with the drug. Neuropeptide release was induced by 80 mM K+ either at the first or second administration. Bradykinin (10 microM) increased the outflow of CGRP-LI, but not of SP-LI, from cerebral venous sinuses. In vitro capsaicin pretreatment (10 microM) or incubation with 10 microM indomethacin completely abolished the bradykinin-evoked CGRP-LI release. Capsaicin (1 microM) failed to evoke release from dura mater without major intracranial venous vessels. Sensory neuropeptide released from the cerebral venous sinuses may take part in certain symptoms, such as vasodilatation and inflammation accompanying the pain of the migraine attack. Bradykinin, putatively via prostanoid generation, may participate in this event.
分别在豚鼠上矢状窦和横窦及其附着的硬脑膜或单独的硬脑膜的灌流液中测量P物质和降钙素基因相关肽样免疫反应性(分别为SP-LI和CGRP-LI)。将脑静脉窦暴露于辣椒素(1微摩尔)会引起SP-LI和CGRP-LI的释放,再次用该药物刺激时不再观察到这种释放。无论是首次还是第二次给药,80毫摩尔钾离子都会诱导神经肽释放。缓激肽(10微摩尔)增加了CGRP-LI从脑静脉窦的流出,但没有增加SP-LI的流出。体外辣椒素预处理(10微摩尔)或与10微摩尔吲哚美辛孵育完全消除了缓激肽引起的CGRP-LI释放。辣椒素(1微摩尔)在没有主要颅内静脉血管的情况下不能从硬脑膜引起释放。从脑静脉窦释放的感觉神经肽可能参与某些症状,如偏头痛发作疼痛伴随的血管扩张和炎症。缓激肽可能通过前列腺素的产生参与这一过程。